Objective—To determine the effects of treatment with platelet- and leukocyte-rich plasma (PRP) on future 2-, 3-, and 4-year-old racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated suspensory ligament branch (SLB) desmitis.
Design—Randomized clinical trial.
Animals—39 yearling Thoroughbreds.
Procedures—Yearling Thoroughbreds with radiographic evidence of performance-limiting proximal sesamoid bone inflammation and ultrasonographic evidence of associated SLB desmitis were identified and randomly assigned to undergo PRP (treatment group) or saline (0.9% NaCl) solution (control group) injection at the affected SLB-proximal sesamoid bone junction. Race records of horses for the 2-, 3-, and 4-year-old racing years were obtained. Data regarding amount of money earned and number of races started were used as outcome measures, and results for groups were compared.
Results—Horses treated with PRP were significantly more likely to start at least 1 race during the 2-year-old racing year than were horses treated with saline solution; no significant differences were detected between groups regarding that variable for the 3- and 4-year-old racing years. No significant differences between groups were detected regarding earnings for any racing year.
Conclusions and Clinical Relevance—Although PRP-treated horses were more likely to start a race during the 2-year-old racing year versus control group horses, results for horses in each group were not significantly different for the 3- and 4-year-old racing years. Therefore, the PRP treatment protocol evaluated in this study did not seem to improve future racing performance of yearling Thoroughbreds with proximal sesamoid bone inflammation and associated SLB desmitis, compared with injection of saline solution.
Objective—To quantify the number of horses with Corynebacterium pseudotuberculosis infection identified in the United States from January 2003 through December 2012.
Sample—State veterinary diagnostic laboratory records of 2,237 C pseudotuberculosis culture-positive samples from horses.
Procedures—44 state veterinary diagnostic laboratories throughout the United States were invited by mail to participate in the study. Data requested included the number of C pseudotuberculosis culture-positive samples from horses identified per year, geographic location from which the C pseudotuberculosis culture-positive sample was submitted, month and year of sample submission, breed and age of horses, and category of clinical manifestation (ie, internal infection, external infection, or ulcerative lymphangitis).
Results—Of the 44 invited laboratories, 15 agreed to participate and provided data on affected horses from 23 states. The proportion of C pseudotuberculosis culture-positive samples submitted during 2011 through 2012 (1,213/2,237 [54%]) was significantly greater than that for the period from 2003 through 2010 (1,024/2,237 [46%]). Corynebacterium pseudotuberculosis was recovered from horses in states where the disease has not been previously recognized as endemic. Affected horses were identified year-round. The greatest proportion of C pseudotuberculosis culture-positive samples was identified during November, December, and January (789/2,237 [35%]). No significant association between the clinical form of disease and age or breed of horse was observed.
Conclusions and Clinical Relevance—The occurrence of C pseudotuberculosis infection in horses increased during the 10-year period, and affected horses were identified throughout the United States. Further studies to determine changes in annual incidence and to identify potential changing climatic conditions or vector populations associated with disease transmission are warranted to help control the occurrence and spread of C pseudotuberculosis infection in horses.
Objective—To determine the chemoprophylactic effect of gallium maltolate on the cumulative incidence of pneumonia caused by Rhodococcus equi infection in foals.
Animals—483 foals born and raised on 12 equine breeding farms with a history of endemic R equi infections.
Procedures—Group 1 foals were treated with a placebo and group 2 foals were treated with gallium maltolate (approx 30 mg/kg, PO, q 24 h) during the first 2 weeks after birth. Foals were monitored for development of pneumonia attributable to R equi infection and for adverse effects of gallium maltolate.
Results—There were no significant differences in the cumulative incidence of R equi pneumonia among the 2 groups.
Conclusions and Clinical Relevance—Chemoprophylaxis via gallium maltolate administered orally at approximately 30 mg/kg daily for the first 2 weeks after birth failed to reduce the cumulative incidence of pneumonia attributable to R equi infection among foals on breeding farms with endemic R equi infections. Further investigation is needed to identify strategies for control of R equi infections.
Objective—To determine the pharmacokinetics of gallium maltolate (GaM) after intragastric administration in adult horses.
Animals—6 adult horses.
Procedures—Feed was withheld for 12 hours prior to intragastric administration of GaM (20 mg/kg). A single dose of GaM was administered to each horse via a nasogastric tube (time 0). Blood samples were collected at various time points from 0 to 120 hours. Serum was used to determine gallium concentrations by use of inductively coupled plasma-mass spectroscopy. Noncompartmental and compartmental analyses of serum gallium concentrations were performed. Pharmacokinetic models were selected on the basis of the Akaike information criterion and visual analysis of plots of residuals.
Results—Serum concentration data for 1 horse were such that this horse was considered an outlier and excluded from noncompartmental and compartmental analyses. Noncompartmental analysis was used to determine individual pharmacokinetic parameters. A 1-compartment model with first-order input and output and lag time was selected as the best-fit model for the data and used to determine mean — SD values for maximum observed serum concentration (0.28 — 0.09 μg/mL), time of maximum concentration (3.09 — 0.43 hours), time to the first measurable concentration (0.26 — 0.11 hours), apparent elimination half-life (48.82 — 5.63 hours), area under the time-concentration curve (20.68 — 757 h—μg/mL), and apparent volume of distribution (73,493 — 18,899 mL/kg).
Conclusion and Clinical Relevance—Further studies are necessary to determine the bioavailability of GaM after intragastric administration in adult horses.
Objective—To compare bony changes in the metacarpophalangeal joint (MCPJ) of racehorses with (cases) and without (controls) biaxial proximal sesamoid bone (PSB) fracture as determined by 2 grading scales applied to images of cadaveric forelimbs obtained by means of standing MRI (sMRI).
Sample—Forelimbs from 74 Thoroughbred racehorses (21 cases and 53 controls) that were euthanized at a Florida racetrack.
Procedures—Both forelimbs were harvested from cases and controls. Each forelimb underwent sMRI to obtain images of the MCPJ. Two grading scales were described and used for image evaluation; one assessed the density of the PSBs, and the other assessed the integrity of the subchondral bone (SCB) plate at the distopalmar aspect of the third metacarpal bone (MC3). Logistic regression was used to compare the grades between case and control limbs.
Results—Biaxial PSB fracture was associated with a total PSB grade (sum of lateral and medial PSB grades) ≥ 5 for the fractured limb, total MC3 SCB grade (sum of lateral and medial MC3 SCB grades) ≥ 5 for the contralateral limb, and the presence of orthopedic disease in the contralateral MC3.
Conclusions and Clinical Relevance—For cases with biaxial PSB fracture, the density of the PSBs in the affected limb was greater and the MC3 of the contralateral limb was more likely to have orthopedic disease, compared with those for controls. Further evaluation of sMRI as a screening tool for identification of racehorses at risk of biaxial PSB fracture is warranted. (J Am Vet Med Assoc 2015;246:661–673)
OBJECTIVE To compare bony changes of the third metacarpal bone (MC3) of Thoroughbred racehorse cadavers with (cases) or without (controls) catastrophic condylar fracture by use of standing MRI.
SAMPLE 140 forelimbs from 26 case horses (both forelimbs) and 88 control horses (single forelimb).
PROCEDURES Bone marrow lesions (BMLs), identified as a decrease in T1-weighted (T1W) signal and increases in T2*-weighted (T2*W) and short tau inversion recovery (STIR) signals, and dense bone volume percentage (DBVP), identified as decreases in T1W, T2*W, and STIR signals, in the distopalmar aspect of MC3 were recorded. Logistic regression was used to compare fractured and nonfractured limbs of cases and fractured limbs of cases with randomly selected limbs of controls.
RESULTS Among cases, fractured limbs were significantly more likely to have BMLs (26/26 [100%]) than were nonfractured limbs (7/26 [27%]). Fractured limbs of cases were significantly more likely to have BMLs (26/26 [100%]) than were limbs of controls (6/88 [7%]). Among cases, there was no significant difference in DBVP between fractured and nonfractured limbs in lateral (26% vs 21%, respectively) or medial (25% vs 20%, respectively) condyles. However, DBVP was significantly greater in fractured limbs of cases than in limbs of controls for lateral (26% vs 16%, respectively) and medial (25% vs 18%, respectively) condyles.
CONCLUSIONS AND CLINICAL RELEVANCE Standing MRI revealed a significantly greater degree of bone change in racehorses with condylar fracture when comparing fractured and nonfractured limbs of case horses and fractured limbs of case horses with randomly selected limbs of control horses.
OBJECTIVE To determine the effects of oral omeprazole administration on the fecal and gastric microbiota of healthy adult horses.
ANIMALS 12 healthy adult research horses.
PROCEDURES Horses were randomly assigned to receive omeprazole paste (4 mg/kg, PO, q 24 h) or a sham (control) treatment (tap water [20 mL, PO, q 24 h]) for 28 days. Fecal and gastric fluid samples were collected prior to the first treatment (day 0), and on days 7, 28, 35, and 56. Sample DNA was extracted, and bacterial 16S rRNA gene sequences were amplified and sequenced to characterize α and β diversity and differential expression of the fecal and gastric microbiota. Data were analyzed by visual examination and by statistical methods.
RESULTS Composition and diversity of the fecal microbiota did not differ significantly between treatment groups or over time. Substantial variation in gastric fluid results within groups and over time precluded meaningful interpretation of the microbiota in those samples.
CONCLUSIONS AND CLINICAL RELEVANCE Results supported that omeprazole administration had no effect on fecal microbiota composition and diversity in this group of healthy adult horses. Small sample size limited power to detect a difference if one existed; however, qualitative graphic examination supported that any difference would likely have been small and of limited clinical importance. Adequate data to evaluate potential effects on the gastric microbiota were not obtained. Investigations are needed to determine the effects of omeprazole in horses with systemic disease or horses receiving other medical treatments.
Objective—To determine whether the concentrations of airborne virulent Rhodococcus equi in stalls housing foals during the first 2 weeks after birth are associated with subsequent development of R equi pneumonia in those foals.
Sample—Air samples collected from foaling stalls and holding pens in which foals were housed during the first 2 weeks after birth.
Procedures—At a breeding farm in Texas, air samples (500 L each) were collected (January through May 2011) from stalls and pens in which 121 foals were housed on day 1 and on days 4, 7, and 14 after birth. For each sample, the concentration of airborne virulent R equi was determined with an immunoblot technique. The association between development of pneumonia and airborne R equi concentration was evaluated via random-effects Poisson regression analysis.
Results—Some air samples were not available for analysis. Of the 471 air samples collected from stalls that housed 121 foals, 90 (19%) contained virulent R equi. Twenty-four of 121 (20%) foals developed R equi pneumonia. Concentrations of virulent R equi in air samples from stalls housing foals that developed R equi pneumonia were significantly higher than those in samples from stalls housing foals that did not develop pneumonia. Accounting for disease effects, air sample concentrations of virulent R equi did not differ significantly by day after birth or by month of birth.
Conclusions and Clinical Relevance—Exposure of foals to airborne virulent R equi during the first 2 weeks after birth was significantly (and likely causally) associated with development of R equi pneumonia.
Objective—To determine concentrations of 2 acute-phase
proteins (serum amyloid A [SAA] and
lipopolysaccharide-binding protein [LBP]) in serum
samples obtained from horses with colic and identify
relationships among these acute-phase proteins and
Animals—765 horses with naturally developing gastrointestinal
tract diseases characterized by colic (ie,
clinical signs indicative of abdominal pain) and 79
healthy control horses; all horses were examined at 2
university teaching hospitals.
Procedure—Serum concentrations of SAA and LBP
were determined by immunoturbidometric and dotblot
Results—SAA and LBP concentrations were determined
for 718 and 765 horses with colic, respectively.
Concentrations of SAA were significantly higher in
nonsurvivors than in survivors, and horses with
enteritis or colitis and conditions characterized by
chronic inflammation (eg, abdominal abscesses, peritonitis,
or rectal tears) had SAA concentrations significantly
greater than those for horses with other conditions.
Serum concentrations of LBP did not correlate
with outcome, disease process, or portion of the
gastrointestinal tract affected.
Conclusions and Clinical Relevance—Circulating
concentrations of SAA were significantly higher at
admission in horses with colic attributable to conditions
having a primary inflammatory cause (eg, enteritis,
colitis, peritonitis, or abdominal abscesses) and
were higher in horses that failed to survive the
episode of colic, compared with concentrations in
horses that survived. Serum concentrations of LBP
did not correlate with survival. Analysis of these findings
suggests that evaluation of SAA concentrations
may be of use in identifying horses with colic attributable
to diseases that have inflammation as a primary
component of pathogenesis. (Am J Vet Res
Objective—To evaluate a real-time quantitative polymerase
chain reaction (QPCR) assay in the detection
and quantitation of virulent Rhodococcus equi.
Sample Population—1 virulent, 2 intermediately virulent,
and 2 avirulent strains of R equi and 16 isolates
of bacteria genetically related to R equi.
Procedure—The QPCR assay was evaluated for
detection and quantitation of the virulence-associated
gene (vapA) of R equi in pure culture and in samples
of tracheobronchial fluid, which were inoculated with
known numbers of virulent R equi. Results were compared
with those derived via quantitative microbial
culture and standard polymerase chain reaction
Results—The QPCR assay detected the vapAgene in
pure culture of R equi and in tracheobronchial fluid
samples that contained as few as 20 CFUs of virulent
R equi/mL and accurately quantitated virulent R equi
to 103 CFUs/mL of fluid. The assay was highly specific
for detection of the vapA gene of virulent R equi
and was more sensitive than standard polymerase
chain reaction for detection of R equi in tracheobronchial
Conclusions and Clinical Relevance—The QPCR
assay appears to be a rapid and reliable method for
detecting and quantitating virulent R equi. The accuracy
of the QPCR assay is comparable to that of
quantitative microbial culture. The increased sensitivity
of the QPCR method in detection of virulent
R equi should facilitate rapid and accurate diagnosis
of R equi pneumonia in foals. (Am J Vet Res